NINTEDANIB ESYLATE

Generic: NINTEDANIB ESYLATE

Macleods Pharmaceuticals LimitedManufacturer
ORALRoute
NINTEDANIB ESYLATEActive Substance
2026-08-03Original Approval

NINTEDANIB ESYLATE is FDA application ANDA219926, sponsored by MACLEODS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DIARRHOEA
89 reports
2
DYSPNOEA
42 reports
3
PNEUMONIA
40 reports
4
PRODUCT USE IN UNAPPROVED INDICATION
39 reports
5
DEATH
31 reports
6
NAUSEA
30 reports
7
COUGH
28 reports
8
FATIGUE
26 reports
9
VOMITING
26 reports
10
DIZZINESS
25 reports